137 related articles for article (PubMed ID: 8061280)
1. L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity?
Smith TS; Parker WD; Bennett JP
Neuroreport; 1994 Apr; 5(8):1009-11. PubMed ID: 8061280
[TBL] [Abstract][Full Text] [Related]
2. L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion.
Camp DM; Loeffler DA; LeWitt PA
J Neurochem; 2000 Mar; 74(3):1229-40. PubMed ID: 10693956
[TBL] [Abstract][Full Text] [Related]
3. Effect of adenosine A(2A) receptor antagonists on L-DOPA-induced hydroxyl radical formation in rat striatum.
Gołembiowska K; Dziubina A; Kowalska M; Kamińska K
Neurotox Res; 2009 Feb; 15(2):155-66. PubMed ID: 19384578
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical effects of adenosine receptor ligands on hydroxyl radical generation by L-DOPA in the rat striatum.
Gołembiowska K; Dziubina A; Kowalska M; Kamińska K
Pharmacol Rep; 2008; 60(3):319-30. PubMed ID: 18622056
[TBL] [Abstract][Full Text] [Related]
5. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
Gołembiowska K; Dziubina A
Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
[TBL] [Abstract][Full Text] [Related]
6. The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.
Gołembiowska K; Dziubina A
Neurotox Res; 2012 Aug; 22(2):150-7. PubMed ID: 22407500
[TBL] [Abstract][Full Text] [Related]
7. Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo.
Wu RM; Chiueh CC; Pert A; Murphy DL
Eur J Pharmacol; 1993 Oct; 243(3):241-7. PubMed ID: 8276076
[TBL] [Abstract][Full Text] [Related]
8. Effects of subchronic treatment with selegiline on L-DOPA-induced increase in extracellular dopamine level in rat striatum.
Adachi K; Miwa H; Kusumoto H; Shimazu S; Kondo T
J Pharmacol Sci; 2006 Aug; 101(4):286-92. PubMed ID: 16891770
[TBL] [Abstract][Full Text] [Related]
9. L-DOPA does not facilitate nitric oxide production in the rat striatum and substantia nigra: in vivo microdialysis study.
Kashihara K; Sakai K; Marui K; Shohmori T
Life Sci; 1998; 63(4):PL59-64. PubMed ID: 9698040
[TBL] [Abstract][Full Text] [Related]
10. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
Biggs CS; Starr MS
Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
[TBL] [Abstract][Full Text] [Related]
11. Rotenone increases glutamate-induced dopamine release but does not affect hydroxyl-free radical formation in rat striatum.
Leng A; Feldon J; Ferger B
Synapse; 2003 Dec; 50(3):240-50. PubMed ID: 14515342
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC
Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430
[TBL] [Abstract][Full Text] [Related]
13. Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.
Serra PA; Esposito G; Enrico P; Mura MA; Migheli R; Delogu MR; Miele M; Desole MS; Grella G; Miele E
Br J Pharmacol; 2000 Jun; 130(4):937-45. PubMed ID: 10864903
[TBL] [Abstract][Full Text] [Related]
14. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
Xu K; Dluzen DE
J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
[TBL] [Abstract][Full Text] [Related]
15. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
Meissner W; Ravenscroft P; Reese R; Harnack D; Morgenstern R; Kupsch A; Klitgaard H; Bioulac B; Gross CE; Bezard E; Boraud T
Neurobiol Dis; 2006 Jun; 22(3):586-98. PubMed ID: 16531050
[TBL] [Abstract][Full Text] [Related]
16. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
Finberg JP; Wang J; Goldstein DS; Kopin IJ; Bankiewicz KS
J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
[TBL] [Abstract][Full Text] [Related]
17. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia.
Chiueh CC; Wu RM; Mohanakumar KP; Sternberger LM; Krishna G; Obata T; Murphy DL
Ann N Y Acad Sci; 1994 Nov; 738():25-36. PubMed ID: 7832434
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
[TBL] [Abstract][Full Text] [Related]
20. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
Lindgren HS; Andersson DR; Lagerkvist S; Nissbrandt H; Cenci MA
J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
